Phoenix Holdings Ltd. Uni Qure N.V. Transaction History

Phoenix Holdings Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$29.24 - $42.03 $4.02 Million - $5.78 Million	-137,412 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$35.35 - $50.67 $707,000 - $1.01 Million	20,000 Added 17.03%	137,412 $4.96 Million
Q2 2020 Aug 10, 2020	SELL	$45.06 - $67.74 $163,567 - $245,896	-3,630 Reduced 3.0%	117,412 $5.02 Million
Q1 2020 May 20, 2020	BUY	$40.01 - $73.97 $1.37 Million - $2.53 Million	34,242 Added 39.45%	121,042 $5.61 Million
Q4 2019 Feb 18, 2020	BUY	$37.13 - $74.62 $3.22 Million - $6.48 Million	86,800 New	86,800 $6.18 Million

141

33.7M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $230M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.